New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

尽管不受委员会建议的约束，但 FDA 在做出批准决定时会考虑这些建议。预计将于 2024 年 12 月 20 日做出监管决定。如果获得批准，索他格列净将成为首个用于治疗 1 型糖尿病患者的口服药物。

The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...

The FDA said it is evaluating the need for additional regulatory action regarding the safety of bluebird bio’s (NASDAQ:BLUE) ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...

“Phenylephrine is an oral decongestant and vasoconstrictor,” Valley Health Pharmacist Dr. Aaron Stone. “By that, it means it ...

A recent slew of food recalls is raising questions about the government’s ability to ensure food safety. Former FDA official Susan Mayne and New York Times reporter Christina Jewett join Meet the ...

Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...

President-elect Donald Trump is stacking the Department of Health and Human Services with people who are poised to favor the ...